PledPharma presents results from study on drug candidate Aladote® for paracetamol poisoning at a global toxicology conference
December 13, 2018 02:00 ET
|
PledPharma AB
Stockholm, December 13, 2018. PledPharma AB (publ) announces that the company's Aladote® Phase Ib/IIa study results has been accepted for a poster presentation during the “58th Annual Meeting of the...
PledPharma redovisar positiva slutresultat från klinisk proof of principle-studie av Aladote®
September 24, 2018 02:30 ET
|
PledPharma AB
Stockholm, 24 september 2018. PledPharma AB (publ) meddelar idag att proof of principle-studien av Aladote® framgångsrikt har slutförts, och att studiens primära syfte – att dokumentera...
Pledpharma announces positive results from the Aladote® proof of principle study
September 24, 2018 02:30 ET
|
PledPharma AB
Stockholm, September 24, 2018. Today PledPharma (publ) announces that the Aladote® proof of principle study in patients with paracetamol overdose at risk of liver damage has successfully met the...
Global Para Nitrochlorobenzene (PNCB) Market to witness a CAGR of 3.3% during 2018-2024
August 27, 2018 06:01 ET
|
Energias Market Research
NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- The global para nitrochlorobenzene (PNCB) market was valued at USD 96.0 million in 2017 and is likely to expand to USD 120.4 million by 2024, witnessing a...
Aladote® uppvisar god säkerhetsprofil i den första kliniska studien – PledPharma planerar ansöka om särläkemedelsstatus i USA
June 25, 2018 02:30 ET
|
PledPharma AB
PledPharma AB (publ) meddelar idag resultaten från en oberoende utvärdering av data från den kliniska proof-of-principle-studien (fas 1b/2a) av Aladote®. Utvärderingen, som utförts av studiens Data...
Aladote® is concluded as safe in first clinical study – PledPharma aims to apply for Orphan Drug Status in the US
June 25, 2018 02:30 ET
|
PledPharma AB
Today PledPharma (publ) announces that the company has received a positive conclusion of the safety evaluation from the Data Safety Monitoring Board for the Aladote proof of principle study in...
Can Common Pain Relievers Do More Harm Than Good?
September 20, 2011 11:26 ET
|
BioResource, Inc.
SAN FRANCISCO, CA--(Marketwire - Sep 20, 2011) - When it comes to relieving the common headache or body aches, it seems as if the cure may be worse for you than the pain it's supposed to relieve.
...
Statement From the Consumer Healthcare Products Association on Today's Joint FDA Advisory Committee Recommendations on Over-the-Counter Medicines Containing Acetaminophen
June 30, 2009 19:00 ET
|
Consumer Healthcare Products Association
WASHINGTON, DC--(Marketwire - June 30, 2009) - Following is a statement by Linda A. Suydam,
D.P.A., president of the Consumer Healthcare Products Association (CHPA), regarding the
recommendations...